Skip to content
Creatinine ClearanceCalculator · the Gault Standard

Hydrochlorothiazide Renal Dose Adjustment by Creatinine Clearance

Gout, GI, Oncology & Other · renal dosing

Medically reviewed by Dr. Rishi Kumar Kafle, MBBS, MD, FASN · Last reviewed June 2026

Hydrochlorothiazide is dosed by eGFR: Ineffective eGFR <30 (switch to loop).

Reviewed by Dr. Rishi Kumar Kafle, MBBS, MD, FASN — always confirm against the label

How Hydrochlorothiazide Is Dosed by eGFR

Hydrochlorothiazide is cleared, wholly or partly, by the kidneys. As filtration falls, the drug or its active metabolites clear more slowly and can accumulate, which raises the risk of ineffective at low GFR. The renal dose-adjustment rule for Hydrochlorothiazide is therefore based on eGFR. The summary below is reference-level; the linked FDA label is the authority for the exact numbers.

Hydrochlorothiazide renal dosing summary (verify against the FDA label)
ParameterValue
Renal estimate usedeGFR
Dose adjustmentIneffective eGFR <30 (switch to loop)
Key cautionineffective at low GFR
Drug classGout, GI, Oncology & Other

The Creatinine-Clearance Dose-Band Framework

Most renally-cleared drugs are adjusted across four broad creatinine-clearance bands — above 50, 30–50, 15–30, and below 15 mL/min — by lowering the dose or lengthening the interval as clearance falls. Hydrochlorothiazide's own cutoff (above) takes precedence over this general framework when the two differ, because each label sets its threshold from that drug's pharmacokinetics and therapeutic window.

General renal dose-band framework (drug-specific cutoffs override)
Creatinine clearance (mL/min)Typical adjustment
> 50usually standard dosing
30–50reduce dose or extend interval for many agents
15–30further reduction; some drugs avoided
< 15 (or dialysis)lowest dosing or an alternative agent; dialysis timing may matter

Why Hydrochlorothiazide Accumulates as Kidney Function Falls

The kidneys normally remove Hydrochlorothiazide (or its active metabolites) at a rate that tracks glomerular filtration. As filtration falls, that removal slows, the drug's effective half-life lengthens, and each dose lingers longer before the next is given. Without adjustment, successive doses stack up and the steady-state concentration climbs into the range where ineffective at low GFR become likely. Lowering the dose or lengthening the interval restores a safe average concentration while preserving the therapeutic effect. This is why the cutoff is expressed in eGFR rather than serum creatinine alone — the same creatinine maps to very different clearances depending on age, sex, and body size.

Severe Impairment and Dialysis

At a eGFR below 15 mL/min/1.73m², or on dialysis, dosing for Hydrochlorothiazide usually moves to the lowest end of the range or to an alternative agent, and the timing of doses around a dialysis session can matter when the drug is dialysable. Decisions at this level of kidney function are best made with pharmacy or nephrology input and the patient's measured response, not an estimate alone. See when dialysis is started for context.

How to Calculate eGFR for Hydrochlorothiazide

Estimate the patient's renal function first, then apply the threshold above. Use the eGFR calculator (CKD-EPI 2021) for Hydrochlorothiazide. For example, a 70-year-old, 70 kg patient with a serum creatinine of 1.4 mg/dL has a Cockcroft–Gault creatinine clearance near 50 mL/min — close to the band where many drugs in this class need adjustment.


Monitoring and Re-Estimating

The key caution for Hydrochlorothiazide is ineffective at low GFR. Kidney function is not static: acute illness, dehydration, contrast, and other nephrotoxic drugs can lower it within days, so re-estimate eGFR whenever the clinical picture changes rather than relying on an old value. A creatinine that is still rising or falling has not reached steady state, and any estimate from it — including for Hydrochlorothiazide — is provisional until the value stabilises.

Re-check renal function and reconsider the Hydrochlorothiazide dose when any of the following appear, since each can signal falling clearance or early accumulation:

  • a rising serum creatinine or a falling urine output;
  • a new or worsened symptom consistent with ineffective at low GFR;
  • a new nephrotoxic drug, contrast exposure, dehydration, or acute illness;
  • a measured drug level outside its target range, where monitoring applies.

Special Populations

  • Older adults: low muscle mass keeps serum creatinine deceptively normal, so clearance — and the safe Hydrochlorothiazide dose — can be lower than the lab value suggests.
  • Obesity: total body weight overestimates clearance; use adjusted body weight in the Cockcroft–Gault equation.
  • Acute kidney injury: a non-steady-state creatinine makes any estimate unreliable; dose conservatively and recheck.

Other Renally-Dosed Gout, GI, Oncology & Other

Frequently Asked Questions

How is Hydrochlorothiazide dosed in renal impairment?
Hydrochlorothiazide is dosed by eGFR: Ineffective eGFR <30 (switch to loop). Always confirm against the current drug label and the patient's measured renal function.
Does Hydrochlorothiazide use creatinine clearance or eGFR?
Hydrochlorothiazide is labelled by eGFR (mL/min/1.73m²), so use an eGFR estimate rather than Cockcroft–Gault creatinine clearance for this drug.
What eGFR threshold changes the Hydrochlorothiazide dose?
Ineffective eGFR <30 (switch to loop). Calculate the patient's eGFR first, then apply this rule and confirm against the current label.

References

  1. DailyMed (NLM/FDA). Hydrochlorothiazide — FDA-approved prescribing information (drug label).
  2. Drugs@FDA. Hydrochlorothiazide approval and labeling history.
  3. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD (drug dosing in reduced kidney function).